Position in GRAL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,343,024
-$5,339,995 QoQ
Shares Held
64,687
-36.2% QoQ
Ownership
0.151%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $1,108,346,968 across 33 Diagnostics & Research names. GRAL ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
4,229,531 | $390,681,778 | |
| 2 | DHR |
Danaher Corp /De/
|
1,858,782 | $352,425,067 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
187,893 | $92,355,046 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
176,557 | $84,780,905 | |
| 5 | A |
Agilent Technologies, Inc.
|
677,347 | $77,204,011 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
219,984 | $37,516,071 | |
| 7 | ILMN |
Illumina, Inc.
|
73,717 | $9,086,357 | |
| 8 | NTRA |
Natera, Inc.
|
40,200 | $8,039,598 |
All Filings in GRAL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,343,024 | 64,687 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,683,019 | 101,449 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,694,002 | 147,032 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $13,041,140 | 253,620 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,795,913 | 266,089 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,724,845 | 96,630 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||